Table 3.

Multivariate analysis of predictive factors for response to cyclosporine therapy at 6 months.

Variable	Risk ratio	95% confidence interval	P
Age at diagnosis, years: >4.7 vs. ≤4.7	1.24	0.30–5.14	0.768
Sex: male vs. female	1.56	0.39–6.44	0.539
Presenting symptoms: Infection vs. other	3.38	0.68–16.70	0.136
Neutrophils (/µl): ≥500 vs. <500	0.22	0.05–0.96	0.043
Platelets (×103/µl): ≥20 vs. <20	1.36	0.33–5.61	0.674
Reticulocytes (103/µl): ≥20 vs. <20	0.43	0.11–1.73	0.235
CD56+ vs. CD56−	0.21	0.05–0.93	0.040

Values in bold denote statistical significance at the level P < 0.05.